UNSPSC 51333514: Pridinol methanesulfonate

This classification denotes an antipsychotic agent with the molecular formula C20H25NO.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AQ4K0AJT6G, chemically known as 1,1-diphenyl-3-piperidinopropan-1-ol methanesulphonate, but more generally known as pridinol methanesulfonate, which bears US NIH Compound Identifier 165542. European Medicines Agency schedules pridinol methanesulfonate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10037MIG.

Most nations, for tariff purposes, schedule pridinol methanesulfonate under HS 29333999. SMILES: CS(=O)(=O)O.C1CCC(CC1)C(CCN2CCCCC2)(C3CCCCC3)O.

UNSPSC 51333514 Pridinol methanesulfonate is a Commodity code for a specific pharmaceutical compound. However, the recent state and local procurement activity tagged under this code does not reflect acquisition of pridinol methanesulfonate itself. Instead, Seminole County, Florida has posted a solicitation for naloxone and safe drug deactivation systems — products unrelated to the nominal scope of the code. The mismatch suggests either a tagging error in the source data or a divergence between the code's formal definition and how it is applied in practice by issuing jurisdictions. State and local governments may use this code for emergency-response pharmaceutical procurement more broadly, but the single recent opportunity available does not support a reliable characterization of genuine pridinol methanesulfonate demand.

Seminole County, Florida released an Invitation for Bid (IFB 60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023. The county requires quarterly deliveries to its Community Health Building in Sanford, Florida, with all shipping and delivery costs included in vendor proposals. The contract carries a two-year initial term with a one-year renewal option, includes a three-month probationary period, and mandates E-Verify compliance, workers' compensation insurance, and drug-free workplace certification. The procurement does not list explicit set-aside designations. Beyond this single opportunity, the source provides no other recent state or local solicitations under this code, limiting visibility into broader activity or issuing-body patterns.